Neogen Corp. buy melinda
Startpreis
17.11.18
/
50%
28,63 €
Kursziel
22.01.19
30,22 €
Rendite (%)
-4,58 %
Endpreis
22.01.19
27,32 €
Zusammenfassung
Diese Einschätzung wurde am 22.01.19 mit einem Endkurs von 27,32 € beendet. Die BUY Einschätzung von melinda konnte mit einer Rendite von -4,58 % nicht überzeugen. melinda hat 50% Zuversicht bei dieser EinschätzungRendite ohne Dividenden (%)
Name | 1W | 1M | 1J | 3J |
---|---|---|---|---|
Neogen Corp. | 1,83 % | 1,83 % | -27,92 % | -71,90 % |
iShares Core DAX® | -1,37 % | -3,23 % | 11,66 % | 16,54 % |
iShares Nasdaq 100 | 0,17 % | -3,34 % | 36,49 % | 43,33 % |
iShares Nikkei 225® | -0,80 % | -7,86 % | 18,60 % | 4,25 % |
iShares S&P 500 | -0,37 % | -2,98 % | 26,34 % | 40,91 % |
Was spricht laut melinda für und gegen Neogen Corp. in den nächsten Jahren?
Pro
Eventuell lohnenswerte Investition > 10% pro Jahr
Kontra
Kommentare von melinda zu dieser Einschätzung
In der Diskussion Neogen Corp. diskutieren
SecteurEquipement, fournitures et distribution médicale Agenda 26/03 Publication de résultats
Manufactures and markets medical testing kits
Neogen Corp. engages in the development, manufacture, and sale of products dedicated to food and animal safety.
It operates through the following segments: Food Safety, Animal Safety, and Corporate.
The Food Safety segment consists of the development, production and marketing of diagnostic test kits, dehydrated culture media and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens, drug residues, and levels of general sanitation.
The Animal Safety segment includes the development, production and marketing of products dedicated to animal safety, including a complete line of consumable products marketed to veterinarians and animal health product distributors.
The Corporate segment refers to the corporate assets, including cash and cash equivalents, marketable securities, current and deferred tax accounts, and overhead expenses not allocated to specific business segments.
The company was founded on June 30, 1981 and is headquartered in Lansing, MI.
Neogen Corp. engages in the development, manufacture, and sale of products dedicated to food and animal safety.
It operates through the following segments: Food Safety, Animal Safety, and Corporate.
The Food Safety segment consists of the development, production and marketing of diagnostic test kits, dehydrated culture media and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens, drug residues, and levels of general sanitation.
The Animal Safety segment includes the development, production and marketing of products dedicated to animal safety, including a complete line of consumable products marketed to veterinarians and animal health product distributors.
The Corporate segment refers to the corporate assets, including cash and cash equivalents, marketable securities, current and deferred tax accounts, and overhead expenses not allocated to specific business segments.
The company was founded on June 30, 1981 and is headquartered in Lansing, MI.
Nombre d'employés : 1 546 personnes.
(Vom Mitglied beendet)
Beendete Einschätzungen von melinda zu Neogen Corp.
Neogen Corp.
Startkurs
Kursziel
Rendite (%)
35,40 €
14.12.21
14.12.21
38,00 €
14.12.22
14.12.22
-59,89 %
15.12.22
15.12.22
Eventuell lohnenswerte Investition > 10% pro Jahr
Neogen Corp.
Startkurs
Kursziel
Rendite (%)
21,34 €
04.04.17
04.04.17
22,32 €
02.06.17
02.06.17
4,72 %
02.06.17
02.06.17
Eventuell lohnenswerte Investition > 10% pro Jahr
Neogen Corp.
Startkurs
Kursziel
Rendite (%)
11,09 €
28.09.13
28.09.13
11,75 €
27.11.13
27.11.13
20,15 %
27.11.13
27.11.13
Eventuell lohnenswerte Investition > 10% pro Jahr